Top Markets
#1 Pons Pons +54.09%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Purr Purr +49.34%
#4 Kinetiq Kinetiq +27.31%
#5 Non-Playable Coin Non-Playable Coin +26.21%
#6 ApeX ApeX +25.57%
#7 Pudgy Penguins Pudgy Penguins +21.07%
#8 OriginTrail OriginTrail +20.36%
#9 Morpho Morpho +20.09%
#10 Grass Grass +19.96%
Coin of the day
Pons Pons
設定
言語
日本
通貨
USD
テーマ
3B BlackBio Dx Ltd 3B BlackBio Dx Ltd

3B BlackBio Dx Ltd

3BBLACKBIO
株式のランク #21276
Established in 1972 and headquartered in Bhopal, India, 3B Blackbio Dx Limited... Established in 1972 and headquartered in Bhopal, India, 3B Blackbio Dx Limited specializes in the conception, production, and market distribution of sophisticated molecular diagnostic technologies. The company's core focus is on delivering solutions for pressing health concerns such as infectious diseases, oncology, human genetics, and the challenge of antimicrobial resistance, primarily serving the Indian market. Their comprehensive product portfolio includes qPCR-based assays, swift lateral flow rapid tests, and cutting-edge Next Generation Sequencing (NGS) molecular diagnostic kits. These offerings are designed to enable precise and dependable analysis of patient samples by diagnostic laboratories, marketed under reputable brands like TRUPCR, TRUNGS, and TRURAPID. Beyond diagnostics, 3B Blackbio Dx Limited also supplies agrochemical products and provides essential technical support and training services.
株価
$12.94
最終同期: 2026-08-21
時価総額
$111.10M
変化（1日）
3.03%
変化（1年）
-21.30%
国
IN
取引 3B BlackBio Dx Ltd (3BBLACKBIO)

カテゴリー

Healthcare
3B BlackBio Dx Ltd（3BBLACKBIO）の収益
Aug 2026 時点の収益 TTM: 0
3B BlackBio Dx Ltd の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
3B BlackBio Dx Ltd の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH